Christoph Grundner, Ph.D.
Seattle Children's Hospital
Developing a Unique Dual-Action Compound to Treat Drug-Resistant TB
Page last updated: March 8, 2022
Seattle Children's Hospital
Developing a Unique Dual-Action Compound to Treat Drug-Resistant TB
Page last updated: March 8, 2022
Your tax-deductible donation funds lung disease and lung cancer research, new treatments, lung health education, and more.
Make a Donation